André Haman

1.3k total citations
25 papers, 930 citations indexed

About

André Haman is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, André Haman has authored 25 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Hematology and 8 papers in Immunology. Recurrent topics in André Haman's work include Acute Myeloid Leukemia Research (11 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Immune Cell Function and Interaction (5 papers). André Haman is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Immune Cell Function and Interaction (5 papers). André Haman collaborates with scholars based in Canada, France and China. André Haman's co-authors include T Hoang, Daniel Rajotte, GG Wong, Trang Hoang, Pierre S. Haddad, Edward J. Cragoe, SC Clark, Guy Sauvageau, Beth Levy and Carlos Rodríguez and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

André Haman

24 papers receiving 905 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
André Haman Canada 18 464 365 310 216 81 25 930
T Hoang Canada 12 342 0.7× 336 0.9× 389 1.3× 175 0.8× 49 0.6× 19 849
Dorothy J. Park United States 15 549 1.2× 299 0.8× 311 1.0× 205 0.9× 99 1.2× 22 917
Satsuki Iwase Japan 17 595 1.3× 383 1.0× 244 0.8× 543 2.5× 132 1.6× 37 1.2k
M Durstin United States 10 382 0.8× 243 0.7× 306 1.0× 197 0.9× 45 0.6× 11 786
K Yamamoto Japan 8 318 0.7× 429 1.2× 208 0.7× 534 2.5× 91 1.1× 14 1.0k
Magali Herrant France 10 637 1.4× 179 0.5× 180 0.6× 200 0.9× 95 1.2× 11 883
Susan Rice United States 15 589 1.3× 330 0.9× 441 1.4× 256 1.2× 283 3.5× 24 1.2k
Andrea Hoelbl‐Kovacic Austria 17 481 1.0× 306 0.8× 474 1.5× 424 2.0× 122 1.5× 24 1.2k
Kanteti V. Prasad United States 12 380 0.8× 149 0.4× 226 0.7× 167 0.8× 70 0.9× 14 697
Ricardo López‐Pérez Spain 18 614 1.3× 131 0.4× 448 1.4× 222 1.0× 90 1.1× 36 1.0k

Countries citing papers authored by André Haman

Since Specialization
Citations

This map shows the geographic impact of André Haman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Haman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Haman more than expected).

Fields of papers citing papers by André Haman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Haman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Haman. The network helps show where André Haman may publish in the future.

Co-authorship network of co-authors of André Haman

This figure shows the co-authorship network connecting the top 25 collaborators of André Haman. A scholar is included among the top collaborators of André Haman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Haman. André Haman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Veiga, Diogo F. T., Mathieu Tremblay, Bastien Gerby, et al.. (2022). Monoallelic Heb/Tcf12 Deletion Reduces the Requirement for NOTCH1 Hyperactivation in T-Cell Acute Lymphoblastic Leukemia. Frontiers in Immunology. 13. 867443–867443. 3 indexed citations
2.
Smith, Matthew J., Noboru Ishiyama, Marilyn Goudreault, et al.. (2017). Evolution of AF6-RAS association and its implications in mixed-lineage leukemia. Nature Communications. 8(1). 1099–1099. 22 indexed citations
3.
Sincennes, Marie‐Claude, Magali Humbert, Benoı̂t Grondin, et al.. (2016). The LMO2 oncogene regulates DNA replication in hematopoietic cells. Proceedings of the National Academy of Sciences. 113(5). 1393–1398. 24 indexed citations
4.
Tremblay, Mathieu, Magali Humbert, Benoı̂t Grondin, et al.. (2013). RARα-PLZF oncogene inhibits C/EBPα function in myeloid cells. Proceedings of the National Academy of Sciences. 110(33). 13522–13527. 28 indexed citations
5.
Lacombe, Julie, Sabine Herblot, Shanti Rojas‐Sutterlin, et al.. (2009). Scl regulates the quiescence and the long-term competence of hematopoietic stem cells. Blood. 115(4). 792–803. 64 indexed citations
6.
Lacombe, Julie, Sabine Herblot, Shanti Rojas‐Sutterlin, et al.. (2009). SCL regulates the Quiescence and the Long-Term Competence of Hematopoietic Stem Cells.. Blood. 114(22). 2520–2520. 1 indexed citations
7.
Lécuyer, Éric, Marie‐Claude Sincennes, André Haman, et al.. (2007). Protein Stability and Transcription Factor Complex Assembly Determined by the SCL-LMO2 Interaction. Journal of Biological Chemistry. 282(46). 33649–33658. 34 indexed citations
8.
Tremblay, Mathieu, André Haman, Benoı̂t Grondin, et al.. (2007). The RARa-PLZF Oncogenic Protein Inhibits C/EBPa Function in Myeloid Cells.. Blood. 110(11). 1825–1825. 1 indexed citations
9.
Grondin, Benoı̂t, Martin Lefrançois, Mathieu Tremblay, et al.. (2007). c-Jun Homodimers Can Function as a Context-Specific Coactivator. Molecular and Cellular Biology. 27(8). 2919–2933. 40 indexed citations
10.
Cáceres‐Cortés, Julio Roberto, Kazuo Waga, Alberto Monroy, et al.. (2001). Implication of tyrosine kinase receptor and steel factor in cell density-dependent growth in cervical cancers and leukemias.. PubMed. 61(16). 6281–9. 49 indexed citations
11.
Senis, Yotis A., et al.. (1999). Targeted Disruption of the Murine fps/fes Proto-Oncogene Reveals that Fps/Fes Kinase Activity Is Dispensable for Hematopoiesis. Molecular and Cellular Biology. 19(11). 7436–7446. 42 indexed citations
12.
Þorsteinsdóttir, Unnur, et al.. (1999). The Oncoprotein E2A-Pbx1a Collaborates with Hoxa9 To Acutely Transform Primary Bone Marrow Cells. Molecular and Cellular Biology. 19(9). 6355–6366. 62 indexed citations
13.
Haman, André, et al.. (1999). Molecular Determinants of the Granulocyte-Macrophage Colony-stimulating Factor Receptor Complex Assembly. Journal of Biological Chemistry. 274(48). 34155–34163. 18 indexed citations
14.
Rajotte, Daniel, André Haman, Sylvain Meloche, et al.. (1996). Contribution of both STAT and SRF/TCF to c-fos promoter activation by granulocyte-macrophage colony-stimulating factor. Blood. 88(8). 2906–2916. 47 indexed citations
15.
Léan, A. De, et al.. (1993). The structure and dynamics of the granulocyte macrophage colony-stimulating factor receptor defined by the ternary complex model. Journal of Biological Chemistry. 268(16). 11881–11887. 17 indexed citations
17.
Hoang, T, Beth Levy, N Onetto, André Haman, & Carlos Rodríguez. (1989). Tumor necrosis factor alpha stimulates the growth of the clonogenic cells of acute myeloblastic leukemia in synergy with granulocyte/macrophage colony-stimulating factor.. The Journal of Experimental Medicine. 170(1). 15–26. 61 indexed citations
18.
19.
Hoang, T, André Haman, F Letendre, et al.. (1988). Interleukin 1 enhances growth factor-dependent proliferation of the clonogenic cells in acute myeloblastic leukemia and of normal human primitive hemopoietic precursors.. The Journal of Experimental Medicine. 168(2). 463–474. 76 indexed citations
20.
Ak, Srivastava, et al.. (1988). Inhibitory effect of the regulatory subunit of type I cAMP-dependent protein kinase on phosphoprotein phosphatase.. PubMed. 16(2). 303–10. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026